LEXEO Therapeutics Company
LEXEO Therapeutics is a biotechnology company.
Investors
Founded Date:
2018-01-01
Funding Status:
Early Stage Venture
Total Funding:
185000000.0
Employee Number:
11-50
Headquarters:
New York, New York, United States
Last Funding Date:
2021-09-09
Investors Number:
16.0
Last Funding Type:
Series B
Estimated Revenue:
$1M to $10M
Industry:
Early Drug Development